Press releases

Sequana Medical Announces Results of the MOSAIC trial data presented at 2017 AASLD

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced that Prof. Florence Wong, University of Toronto, presented the findings of the MOSAIC study data at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Annual Meeting (The...

Sequana Medical Announces 2017 AASLD Poster Presentation

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced that it will have a poster presentation at the upcoming Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Annual Meeting (The Liver Meeting®), being held October 20-24 in...

Sequana Medical Announces Publication of Results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T).

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of “Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis”, the results of the first 56 patients in the alfapump® multicentre Post-Marketing Surveillance Registry (PMSR) in AP&T...

Sequana Medical announces publication of results of Multicentre Randomized Controlled Study for the alfapump®

Sequana Medical AG (“Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of a multicentre, randomized controlled trial in the Journal of Hepatology. The study demonstrated that in patients with refractory ascites, the alfapump®: significantly reduces the requirement for LVP compared to standard of...

Sequana Medical Announces Sudden Passing of Founder, President & CEO

The Board of Directors of Sequana Medical AG (“Sequana Medical” or the “Company”) announces with great sadness, the sudden death of its Founder, President and Chief Executive Officer, Noel L. Johnson, Ph. D. Dr. Johnson founded the Company in 2006 and has served as President and Chief Executive Officer since then. Noel originated the idea...

Ian Crosbie joins Sequana Medical as Chief Financial Officer

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems that manage fluid build-up occurring in patients with liver disease, heart disease and certain cancers, announced today the appointment of Ian Crosbie as Chief Financial Officer. “We are delighted to welcome Ian to Sequana Medical....

Former Bayer and Pharmacia Senior Executive Rolf A. Classon joins the Sequana Medical AG Board as Chairman

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems to manage fluid build-up in patients with liver disease, congestive heart failure and certain cancers, announced today that Rolf A. Classon, former top executive of Bayer AG and Pharmacia AB, has been appointed Chairman of...

Sequana Medical AG raises CHF 9 million (USD 9.3M) in a Series C Extension

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative implantable pump systems that manage excess fluid within the body, announced today that it has raised CHF 9 million ($9.3 million) in a Series C extension round. Existing investors including NeoMed Management AS, VI Partners AG, Biomed Invest...

Sequana Medical presented the alfapump® system at this year’s Viszeralmedizin Congress in Leipzig, Germany

Sequana Medical was delighted to present the alfapump system for the third time at this year’s nationwide Viszeralmedizin Congress, organised by the DGVS (German Society for Gastroenterology, Digestive and Metabolic Diseases) and the DGAV (German Society for General and Visceral Surgery), held in Leipzig’s CCL Congress Centre. This year, we were proud to organise a...